Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Dogecoin Cash, Inc.

Get SEC filing alerts via email and in your feed for Dogecoin Cash, Inc.

CBDS DOGP

Dogecoin Cash, Inc.

About Dogecoin Cash, Inc.

Dogecoin Cash, Inc. operates primarily in telemedicine and digital asset sectors, offering online medical marijuana evaluations via PrestoDoctor. The company also explores branding, licensing, and marketing of cannabis and CBD products, including personal care and infused items. Its business model combines telehealth services with brand development and cryptocurrency integration, targeting markets in states with cannabis legalization, emphasizing innovation, strategic acquisitions, and digital assets.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Dogecoin Cash, Inc.

1
1
Dogecoin Cash, Inc. Dogecoin Cash, Inc. Reports 5% Revenue Increase but Faces $200K Net Loss in Q1 2026

Via official filing (AI summary) | 21 days ago | 0 comments

2
1
Dogecoin Cash, Inc. Dogecoin Cash, Inc. Reports $738,907 Revenue for Fiscal Year 2025, 8% Decrease

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
Dogecoin Cash, Inc. Dogecoin Cash, Inc. Reports Slight Revenue Increase in Q3 2025 Amid Ongoing Challenges

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Dogecoin Cash, Inc. Dogecoin Cash, Inc. Reports 18% Revenue Decline in Q2 2025 Amid Increased Competition

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Dogecoin Cash, Inc. Dogecoin Cash, Inc. Reports 32% Revenue Decline, Focuses on Cryptocurrency Integration

Via official filing (AI summary) | about 1 year ago | 0 comments